Stage 4 pancreatic cancer represents advanced disease where cancer has spread beyond the pancreas to distant organs, requiring comprehensive treatment strategies that balance disease control with quality of life. TL;DR FOLFIRINOX and gemcitabine plus nab-paclitaxel remain first-line chemotherapy options for stage 4 pancreatic cancer, with median survival ranging from 6.8 to 11.1 months depending on regimen and patient fitness [1] Dr. Bharat Patodiya provides comprehensive tre